Repligen (RGEN) Cash from Operations Growth (1y) (2011 - 2026)
Repligen (RGEN) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.18 Bn | 121.97 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.34 Bn | 27.68 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.37 Bn | 22.94 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.11 Bn | 13.54 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 186.74% |
| 10 | Repligen | 7.39 Bn | 6.41 Bn | 108.28 Mn | 88.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.57% |
| Dec 31, 2025 | -34.39% |
| Sep 30, 2025 | -2.48% |
| Jun 30, 2025 | -32.19% |
| Mar 31, 2025 | -66.44% |
| Dec 31, 2024 | 34.79% |
| Sep 30, 2024 | 25.72% |
| Jun 30, 2024 | 22.40% |
| Mar 31, 2024 | 300.82% |
| Dec 31, 2023 | -53.03% |
| Sep 30, 2023 | -5.16% |
| Jun 30, 2023 | -24.61% |
| Mar 31, 2023 | -51.74% |
| Dec 31, 2022 | 24.71% |
| Sep 30, 2022 | 83.99% |
| Jun 30, 2022 | 21.43% |
| Mar 31, 2022 | 149.55% |
| Dec 31, 2021 | 233.67% |
| Sep 30, 2021 | 4.63% |
| Jun 30, 2021 | 124.98% |